MS-DRG 827MDC 17
MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC
Related MS-DRGs in MDC 17
820LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC821LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC822LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC823LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC824LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC825LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC826MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC828MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC829MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC830MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC
Frequently asked questions
What is MS-DRG 827?
MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC
What is the relative weight of MS-DRG 827?
MS-DRG 827 has a relative weight of 2.3112 for FY2026, which reflects the relative resource intensity of cases grouped into it.
What is the average length of stay for MS-DRG 827?
The geometric mean length of stay for MS-DRG 827 is 4 days.
What Major Diagnostic Category (MDC) does MS-DRG 827 belong to?
MS-DRG 827 falls under MDC 17: Myeloproliferative Diseases and Disorders, and Poorly Differentiated Neoplasms.
MS-DRG data (FY2026) from the CMS Inpatient Prospective Payment System (IPPS) final rule. Always verify codes with authoritative sources before making billing decisions.